A Promise Without Panacea: Psychedelic-Assisted Therapies in Modern Psychiatry

Mar 2, 2026Cureus

Psychedelic-Assisted Therapies in Modern Psychiatry: Hopeful but Not a Cure-All

AI simplified

Abstract

Psychedelic-assisted therapies show promising therapeutic effects in treating conditions like treatment-resistant depression and PTSD.

  • Psychedelics such as psilocybin and MDMA are being studied in controlled clinical trials for their potential benefits.
  • These compounds may enhance neural plasticity and improve cognitive and emotional flexibility.
  • Emerging evidence suggests that psychedelic therapies could lead to lasting clinical improvements.
  • Challenges include regulatory uncertainty and ethical concerns regarding patient vulnerability.
  • Equitable access to these therapies remains a significant issue in their integration into mental health care.

AI simplified

Full Text

We can’t show the full text here under this license. Use the link below to read it at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free